Abstract. This paper summarises the information given on the 1986 EDTA Registry centre questionnaire which was returned by 82% of the 2,065 known dialysis and transplant centres in 33 European countries. Information is given on the number of patients alive on haemodialysis according to the type of dialysis facilities available where the patient was receiving dialysis and the number of patients receiving special types of dialysis. The centre questionnaire also included questions on testing for HIV infection, serological evidence or symptoms of AIDS and the diagnosis of hepatitis B in patients and staff. The data given in response to these questions are presented together with data on the involvement of dietitians and social workers in the treatment of patients with end stage renal failure. Finally, information on transplant activity in Europe and the treatment policies of transplanting centres is provided.
Introduction
The Registry of the European Dialysis and Transplant Association -European Renal Association (EDTA Registry) collects data from three sources: individual patient, centre and mini questionnaires.
Each centre known to the EDTA Registry is requested annually to complete a centre questionnaire and to provide core summary data on their unit's activity during the year. By repeating each year core questions concerning the number of patients accepted for renal replacement therapy, total number of patients on treatment at the end of the year, and number of patients undergoing special forms of dialysis, the centre questionnaire provides a unique opportunity to analyse trends in many aspects of renal replacement therapy. Apart from these core questions, additional data are requested in order to investigate particular aspects. This is possible due to the flexible format of the centre questionnaire. EDTA Registry data on demography and special topics (for example AIDS and hepatitis) are used not only by those directly involved in medical care but also by national and international health care authorities. The Registry, therefore, feels obliged to present data annually. In this communication, the results of the 1986 centre questionnaire are reported. 162 Report from the EDTA Registry 
Materials and Methods
In early 1987, the centre questionnaire was sent to 2065 centres in 33 countries. After a reminder to return this questionnaire, a response rate of 82% was achieved. However, it should be borne in mind that those centres returning this form did not always complete all the appropriate questions. National keymen and national registries contributed, supplemented and/or corrected data. Data handling was carried out in the offices of the EDTA Registry in London. Table 1 summarises by country the number of centres known to the EDTA Registry. It does not include satellite units whose data are forwarded through the parent centre. In 22 of the 33 countries reporting to the Registry, there was a response rate of 90% or above.
Demography, 1986 (a) Regular Dialysis and Transplantation

(b) Special Forms of Haemodialysis
The Registry has obtained information concerning the use of limited/self-care or satellite units in the treatment of patients on haemodialysis for the first time in 1986. Centres were asked to record separately the numbers of patients alive on 31 December on hospital haemodialysis (excluding limited/self-care), on haemodialysis with limited/self-care in the unit's own hospital, or on haemodialysis with limited/self-care in another unit (e.g., satellite, free-standing unit or other hospital). The numbers provided in response to this question are shown according to country in Table 2 . The same data shown as Centres were also asked to record the number of haemodialysis patients alive at the end of 1986 on bicarbonate haemodialysis, haemofiltration, haemodiafiltration, and haemodialysis combined with haemoperfusion, and the number of patients who were on continuous cycling peritoneal dialysis or on peritoneal dialysis combined with haemodialysis. The numbers given are shown by country in Table 3 . As can be seen in Fig. 2 , the proportion of patients treated by haemofiltration and haemodiafiltration at the end of the years 1982-1986 changed little, whilst the percentage treated by bicarbonate haemodialysis continued to rise rapidly.
proportions are depicted for selected countries in Fig. 1 . This demonstrates widely differing national policies. However, it should be borne in mind that definitions for self-care and limited care are not clearly set and may vary between countries.
(c) AIDS and Hepatitis
In 1985 the Registry added a question to the centre questionnaire regarding the testing of patients for HIV antibodies. Centres were asked if 'no testing' was carried out on their patients with end-stage renal failure, if tests were done 'in selected patients' or 'in most, or all, of their patients'. This question was asked again for 1986 and the replies given are shown by country in Table 4 . Although the practice of testing varied widely between countries, the proportion of centres which reported that no testing was performed decreased between 1985 and 1986 from 57% to 37% (Fig. 3) . Similarly, the proportion of centres who reported HIV testing in most or all of their patients increased from 30% to 47%. Over 60% of centres in Europe were carrying out tests for HIV antibodies in at least some of their patients. The data were examined for those centres who reported no testing for HIV antibodies in their unit. This information is shown for selected countries in Fig. 4 . Centres reported that a total of 225 patients with endstage renal failure and on renal replacement therapy in 1986 had serological evidence of infection with HIV (Table 5) .
As in previous years, the Registry asked centres to report the number of new cases in 1986 of hepatitis B both in patients and staff. Although the number of cases reported was approximately the same as those reported for 1985 [2] , the ratio of cases per thousand patients on hospital haemodialysis was reduced from 21/1000 to 18/ 1000 for patients and from 3.6/1000 to 3.2/1000 for staff (Table 6 ). This decrease was not observed in all countries, and in a few there was actually an increase. 
(d) Dietitians and Social Workers
Centres were asked if 75% or more of their new patients had been seen by a dietitian and/or social worker during the year. Only the 1178 centres which reported having accepted four or more new patients with end-stage renal failure in 1986 were included in the analysis. Of these centres, 1072 provided information concerning dietitians and 1083 concerning social workers. It can be seen from Table 7 that, overall, a greater proportion of centres involved dietitians with new patients (51%) than social workers (36%), though this was not the case in all countries reporting to the Registry. This is illustrated for selected countries, or groups of countries, in Fig. 5 dietitians and in Fig. 6 concerning social workers. The proportion of centres which involved dietitians and social workers is much more impressive in the United Kingdom and Benelux and Nordic countries than in other European countries.
(e) Transplantation Activity
By the end of 1986 approximately 65 000 transplants had been performed in Europe, of which 9216 were performed in 1986 (Table 8 ). The number of transplants performed annually continued to rise and this increase is illustrated in Fig. 7 which shows the number of transplants performed per million population in selected countries for each of the years 1976, 1981 and 1986. Figure 8 shows the proportion of transplants performed in 1986 according to centre activity. Centre activity has been defined by the number of transplants performed in 1986. More than 40% of all grafts were performed in the 49 centres which carried out 51-100 grafts during 1986.
(f) Waiting List for Transplantation
Of all the patients on dialysis at the end of 1986,26% were on a waiting list for cadaver transplant (Table 8) , with marked variation between countries. A 'projected waiting time' was calculated by dividing the number of patients on the waiting list at the end of 1986 by the number of transplants performed during 1986. Figure 9 shows the 'projected waiting time' in selected countries, which range from approximately 6 months in Norway to nearly 8 years in Portugal. Generally the shortest 'projected waiting •Most recent serum reacting with more than 80% of random donor panel times' were calculated for the Nordic countries and Switzerland, countries which have previously demonstrated high transplant activity. Fig. 10 . Centre policy concerning the upper age limit for a donor from which a cadaver kidney would be accepted, according to centre activity.
(g) Cadaveric Kidney Graft Retrieval
The transplant centres were asked for their policy concerning the upper age limit for a donor from which they would accept a cadaver kidney. Table 9 shows the most commonly reported acceptable upper age limit for a donor in selected countries. The centre policy concerning the upper age limit for a donor according to centre activity is shown in Fig. 10 and demonstrates that centres with high transplant activity are more willing to accept donors with a higher age than centres with a low transplant activity. One wonders whether activity is low in some centres because of a reluctance to use donors from the upper age range. It was also found that the greater the centre activity, the higher the proportion of centres which in 1986 sent a surgical team to other hospital(s) to perform cadaver donor nephrectomy (Fig. 11) . The proportion of centres (excluding paediatric units) which sent a surgical team to other hospital(s) for cadaver donor nephrectomy in 1986 according to country or region is shown in Fig. 12 . In Nordic countries this practice has been adopted by nearly all the transplant units (90%), whereas in Spain only a small proportion of transplant units (17%) sent a surgical team to other hospital(s) for procurement of cadaver kidneys.
(h) Immunosuppressive Regimes
Transplant centres were asked to record their policy in 1986 regarding the use of antilymphocyte globulin (ALG), antithymocyte globulin (ATG) or monoclonal antibodies for prophylactic immunosuppression, and the use of ALG, ATG, monoclonal antibodies and plasma exchange for antirejection therapy. Results concerning prophylactic immunosuppression are shown in Table 10 according to country. Twelve per cent of centres reported having used either ALG, ATG or monoclonal antibodies for prophylactic immunosuppression for most or all of their patients, 20% reported one of these immunosuppressive agents for some of their patients, and 62% never to have used any of these agents. Table 12 gives information by country concerning treatment of rejection episodes. Figure 13 shows that the higher the transplant activity, the greater the percentage of centres which used ALG, ATG, monoclonal antibodies or plasma exchange for either prophylactic immunosuppression or treatment of rejection episodes. Most centres performing more than 10 transplants in 1986 used one or several of these agents for the treatment of at least some rejection episodes. 
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A total of 21% of transplant centres were using monoclonal antibodies. Again, there is a relationship between the use of monoclonal antibodies and centre activity. Of centres performing 50-100 transplants in 1986, more than 40% reported at least occasional use of monoclonal antibodies. Approximately 22% of transplant centres reported occasional use of plasma exchange for the treatment of rejection episodes and this percentage did not appear to depend on centre activity.
(i) Combined Kidney and Pancreas Grafts
In 1986,28 centres performed 122 combined kidney/pancreas transplants (Table 11 ). This number should be compared to the 58 grafts reported by 14 centres in 1983 [3] . The numbers for each country are small, with the highest number in 1986 reported from Sweden. All four Swedish transplant centres carried out combined kidney/pancreas transplants and between them reported a total of 31 such grafts.
Conclusions
EDTA Registry centre questionnaire data continues to be an important source for analysing trends in renal replacement therapy. The large number of centres reporting outweighs individual shortcomings in these types of analyses. This paper summarises several topics and, wherever possible, data have been presented on a countrywide basis.
Although there are national variations in treatment, attitudes and modalities, some generalised conclusions can be made. The total number of patients on hospital haemodialysis has started to level off, accompanied by a decrease in the number of patients treated with home haemodialysis. On the other hand, the number of patients alive on CAPD or with a functioning graft continues to increase.
The frequency of new cases of hepatitis B amongst patients and staff declined in 1986. Renal transplant activity is still rapidly increasing, but the number of patients on a waiting list for a renal graft was much higher than the number of available organs in most countries. Also the number of combined kidney/pancreas transplant operations increased, but only a minority of patients with diabetic end-stage renal failure were treated by this procedure.
